Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition

about

Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition

Item

http://www.wikidata.org/entity/Q57179232

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@en

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@nl

type

Item

label

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@en

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@nl

prefLabel

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@en

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@nl

P1476

Renal Outcomes of Antidiabetic ...... tes-A Proposed MARE Definition

@en

P2093

Christoph Wanner

http://www.w3.org/2001/XMLSchema#string

Friedrich C Prischl

http://www.w3.org/2001/XMLSchema#string

P2860

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis.

The effects of glucose-lowering therapies on diabetic kidney disease

Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

P304

1030-1038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2018.04.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30197969

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

type-2 diabetes

P932

6127417

http://www.w3.org/2001/XMLSchema#string